Pretreatment of therapeutic cells with poly(ADP-ribose) polymerase inhibitor enhances their efficacy in an in vitro model of cell-based therapy in myocardial infarct.

Int J Mol Med · 2013 · PMC3573747 · PMID 23165319

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

There was only a nonsignificant trend of such increase when a 100 μM concentration PJ34-treated cardiomyoblasts were used (0.68±0.04%) ( Fig. 5B ).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.